Pharmaceutical

EnWave (TSXV: ENW) provided an update on the 2018 corporate plans for the company and announces an amendment to its investor relations consulting agreement with Adelaide Capital Markets. As quoted in the press release: Moving forward in 2018 calendar year, the Company will continue to focus on the rapid commercialization of Radiant Energy Vacuum (“REV™”) …

EnWave (TSXV: ENW) provided an update on the 2018 corporate plans for the company and announces an amendment to its investor relations consulting agreement with Adelaide Capital Markets.
As quoted in the press release:

Moving forward in 2018 calendar year, the Company will continue to focus on the rapid commercialization of Radiant Energy Vacuum (“REV™”) technology in the food industry, evolving cannabis space and the development of REV™ technology for its pharmaceutical partners. The current pipeline of opportunities remains strong.

Click here for the full press release.

MARKETS

Markets
TSX18861.36-217.28
TSXV617.26-9.08
DOW31097.26+321.83
S&P 5003825.33+39.95
NASD11127.85+99.11
ASX6539.90-28.20

COMMODITIES

Commodities
Gold1809.91-0.13
Silver19.89+0.03
Copper3.61-0.10
Palladium1965.07+9.98
Platinum891.26+2.98
Oil108.46+2.70
Heating Oil3.96+0.13
Natural Gas5.620.00

DOWNLOAD FREE REPORTS

×